TipRanks
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
FHTX
Foghorn Therapeutics
RESEARCH TOOLSreports
Want to see FHTX full AI Analyst Report?

Foghorn Therapeutics (FHTX) Stock News & Sentiment

447 Followers
Foghorn Therapeutics Reports Q2 Results and Pipeline Progress
Premium
Company Announcements
Foghorn Therapeutics Reports Q2 Results and Pipeline Progress
2M ago
8K
FHTX
Foghorn Therapeutics Stockholders Approve Directors and Governance Matters
Premium
Company Announcements
Foghorn Therapeutics Stockholders Approve Directors and Governance Matters
3M ago
8K
FHTX
Foghorn Therapeutics Highlights Q1 Progress in Oncology Pipeline
Premium
Company Announcements
Foghorn Therapeutics Highlights Q1 Progress in Oncology Pipeline
5M ago
8K
FHTX
Foghorn Therapeutics: AACR 2026 Data De‑Risk Pipeline and Expand Commercial Opportunity, Supporting Buy Rating and $13 Target
Premium
Ratings
Foghorn Therapeutics: AACR 2026 Data De‑Risk Pipeline and Expand Commercial Opportunity, Supporting Buy Rating and $13 Target
5M ago
FHTX
Foghorn Highlights Preclinical Chromatin Oncology Advances at AACR
Premium
Company Announcements
Foghorn Highlights Preclinical Chromatin Oncology Advances at AACR
5M ago
8K
FHTX
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
Premium
Ratings
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
6M ago
FHTX
Buy Rating on Foghorn Therapeutics Driven by Lilly Partnership Catalyst, Advancing Degrader Pipeline, and Strengthened Cash Runway
Premium
Ratings
Buy Rating on Foghorn Therapeutics Driven by Lilly Partnership Catalyst, Advancing Degrader Pipeline, and Strengthened Cash Runway
6M ago
FHTX
More FHTX News >

FHTX News on the Web

Here's Why Foghorn Therapeutics Inc. (FHTX) is a Great Momentum Stock to Buy
Zacks
Neutral
Foghorn Therapeutics Stockholders Approve Directors and Governance Matters
TipRanks News
Neutral
Foghorn Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
GuruFocus News
Neutral
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
Zacks
Bearish
Wedbush Reaffirms Their Buy Rating on Foghorn Therapeutics (FHTX)
TipRanks News
Bullish
Foghorn Therapeutics (FHTX) Receives a Buy from Guggenheim
TipRanks News
Bullish
Maintaining Buy on Foghorn: Advancing FHD-909, Productive Discovery Engine, and Cash Runway Drive Attractive Risk–Reward Ahead of Key 2026 Catalyst
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), RegenXBio (RGNX) and Foghorn Therapeutics (FHTX)
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FHTX’s Media Buzz Sentiment?
Currently, no data Available
What is FHTX’s weekly average amount of articles?
In an average week, 2.25 articles about FHTX are published.
    What is FHTX’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CRLCharles River Labs
    DFTXDefinium Therapeutics
    AMRXAmneal Pharmaceuticals
    SMMTSummit Therapeutics
    ABEOAbeona Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week